ArticleMolecular psychiatry2026
NgR-Dependent plasticity in a dCA3
Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The Nogo receptor (NgR), a core receptor for myelin-derived axon growth inhibitors, has been implicated not only in the regulation of synaptic plasticity but also in the pathogenesis of various neuropsychiatric disorders. However, its specific role and the underlying circuit mechanisms in the development of depression remain elusive. This study used a chronic unpredictable mild stress (CUMS) model in male mice and found that the expression of the NgR in the dorsal CA3 (dCA3) region of the hippocampus was significantly increased in depressive-like mice, and it was mainly enriched in glutamatergic neurons with reduced excitability. Downregulation of NgR in dCA3 or enhancement of glutamatergic neuronal excitability significantly alleviated depressive-like behaviors, while upregulation of NgR or inhibition of glutamatergic neuronal excitability promoted stress-induced depressive-like behaviors. Notably, dCA3 glutamatergic neurons specifically project to the dopaminergic neuronal pathway in the ventral tegmental area (VTA) and its downstream dopaminergic projections to the nucleus accumbens (NAc). The inhibition of D1/D2 receptors in the NAc is required for mediating depressive-like behaviors. Furthermore, downregulation of NgR in dCA3 exerts antidepressant-like effects by disinhibiting the neurons projecting to the VTA → NAc pathway. This study systematically reveals the role of NgR in dCA3 glutamatergic neurons and the dCA3
Identifiers
42243297What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.